ADARx Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.90B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product opportunity, where a single therapeutic candidate has the potential to address multiple indications; Onvuzosiran, a clinical program for the prevention of HAE attacks; and ADX-626, a Factor XI (FXI) program for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. It also offers extrahepatic-targeted programs, such as ADX-077, an adipose-targeted obesity program designed to reduce body weight and fat while preserving lean mass; and ADX-199, a neuron-targeted program designed to selectively silence and degrade amyloid-ß precursor protein (APP) mRNA in neurons, which is genetically linked to Alzheimer’s disease. The company was incorporated in 2019 and is based in San Diego, California.
Details
| Name | ADARx Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 100 |
| Founded | 2019 |
| Ipo Date | 2026-09-25 |
| Ceo | Zhen Li |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 17.00 |
| Isin | US00654F1057 |
| Cusip | 00654F105 |
| Cik | 1802369 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Zhen Li, Ph.D. | President, Chief Executive Officer and Director |
| Ryan Fisk, M.B.A. | Chief Financial Officer and Chief Business Officer |
| A. Robert MacLeod, Ph.D. | Chief Scientific Officer |
| Rui Zhu, Ph.D. | Chief Technology Officer |
| Robert Ackles | Chief People Officer |
| Erez Chimovits, M.B.A. | Interim Chairman |
| Ting Feng, Ph.D. | Director |
| Simeon George, M.D., M.B.A. | Director |
| Carl L. Gordon, Ph.D., CFA | Director |
| Ying Huang, Ph.D. | Director |
Contact
| Address | 5871 Oberlin Drive, Suite 200, San Diego, California 92121, United States |
| Phone | (877) 232-7974 |
| Website | https://www.adarx.com |